Table 1.
Patients’ characteristics
| Characteristics | No. of patients | % |
|---|---|---|
| Age (years) | ||
| < 60 | 3 | 9.4 |
| ≥ 60 and < 70 | 14 | 43.8 |
| ≥ 70 and < 80 | 9 | 28.1 |
| ≥ 80 | 6 | 18.8 |
| Hormone therapy before CIRT (months) | ||
| 0 | 3 | 9.4 |
| < 6 | 26 | 81.3 |
| ≥ 6 | 3 | 9.4 |
| T stage | ||
| T1 | 1 | 3.1 |
| T2 | 25 | 78.1 |
| T3 | 5 | 15.6 |
| T4 | 1 | 3.1 |
| Initial PSA (ng/ml) | ||
| < 10 | 17 | 53.1 |
| ≥ 10 and ≤ 20 | 9 | 28.1 |
| > 20 | 6 | 18.8 |
| Gleason score | ||
| 6 | 8 | 25.0 |
| 7 | 12 | 37.5 |
| ≥ 8 | 12 | 37.5 |
| Risk (NCCN) | ||
| Low | 1 | 3.1 |
| Intermediate | 15 | 46.9 |
| High | 10 | 31.3 |
| Very high | 6 | 18.8 |
| Simultaneous integrated boost (SIB) | ||
| Yes | 15 | 46.9 |
| No | 17 | 53.1 |